Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Susan Helen Kim


  • Director at Exicure Inc. (XCUR), 2019-06-14
  • Director at Assembly Biosciences Inc. (ASMB), 2019-05-17
  • Evp, Business Development at Kite Pharma Inc. (KITE), 2017-10-06
  • Director at Sunesis Pharmaceuticals Inc (SNSS), 2015-07-02
  • Director at Immunocellular Therapeutics Ltd. (IMUC), 2014-06-17
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $179.66 3,171 Officer 21,693 2017-09-25 Filing
KITE $120.09 6,251 Officer 18,664 2017-08-10 Filing
KITE $121.37 13,274 Officer 18,664 2017-08-08 Filing
KITE $120.40 31,165 Officer 31,938 2017-08-08 Filing
KITE $119.94 18,936 Officer 63,103 2017-08-08 Filing